Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

TP53 germline mutation testing in early-onset breast cancer: findings from a nationwide cohort

3 Jan 2019

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Cancer-related Molecular Pathways
Share to Genomic variations and chromosomal abnormalities

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 30607672
DOI: 10.1007/s10689-018-00118-0

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

TP53 germline mutation testing in early-onset breast cancer: findings from a nationwide cohortPMID 30607672Read ↗

Early onset HER2-positive breast cancer is associated with germline TP53 mutations.Semantic proximity Read ↗

Prevalence and clinical impact of TP53 germline mutations in Chinese women with breast cancerSemantic proximity Read ↗

Evidence Grows for Universal Germline Genetic Testing for Patients with Breast Cancer.Semantic proximity Read ↗

Germline TP53 pathogenic variants and breast cancer: A narrative review.Semantic proximity Read ↗

Clinical implications of germline mutations in breast cancer: TP53.Semantic proximity Read ↗

Clinical Relevance of TP53 Mutation and Its Characteristics in Breast Cancer with Long-Term Follow-Up DateSemantic proximity Read ↗

Germline mutations of TP53 and BRCA2 genes in breast cancer/sarcoma familiesSemantic proximity Read ↗

Differences in Somatic TP53 Mutation Type in Breast Tumors by Race and Receptor StatusSemantic proximity Read ↗

Prevalence of germline TP53 variants among early-onset breast cancer patients from Polish population.Semantic proximity Read ↗

Germline Genetic Testing in Breast Cancer: Systemic Therapy ImplicationsSemantic proximity Read ↗

Suggested application of HER2+ breast tumor phenotype for germline TP53 variant classification within ACMG/AMP guidelines.Semantic proximity Read ↗

Differences in somatic TP53 mutation type in breast tumors by race and receptor status.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.